152 related articles for article (PubMed ID: 34996465)
1. Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
de Andrade JA; Kulkarni T; Neely ML; Hellkamp AS; Case AH; Culver DA; Guntupalli K; Bender S; Conoscenti CS; Snyder LD;
Respir Res; 2022 Jan; 23(1):3. PubMed ID: 34996465
[TBL] [Abstract][Full Text] [Related]
2. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.
Snyder L; Neely ML; Hellkamp AS; O'Brien E; de Andrade J; Conoscenti CS; Leonard T; Bender S; Gulati M; Culver DA; Kaner RJ; Palmer S; Kim HJ;
Respir Res; 2019 May; 20(1):105. PubMed ID: 31142314
[TBL] [Abstract][Full Text] [Related]
3. Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry.
Swaminathan AC; Hellkamp AS; Neely ML; Bender S; Paoletti L; White ES; Palmer SM; Whelan TPM; Dilling DF;
Ann Am Thorac Soc; 2022 Jun; 19(6):981-990. PubMed ID: 35073248
[No Abstract] [Full Text] [Related]
4. Hospitalizations in patients with idiopathic pulmonary fibrosis.
Kim HJ; Snyder LD; Adegunsoye A; Neely ML; Bender S; White ES; Conoscenti CS; Strek ME;
Respir Res; 2021 Sep; 22(1):257. PubMed ID: 34592998
[TBL] [Abstract][Full Text] [Related]
5. Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.
Case AH; Hellkamp AS; Neely ML; Bender S; Dilling DF; Gulati M; Hotchkin DL; Huie TJ; Lancaster L; Snyder LD; Conoscenti CS; Palmer SM
Ann Am Thorac Soc; 2020 Jun; 17(6):699-705. PubMed ID: 32040340
[No Abstract] [Full Text] [Related]
6. Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry.
Kim HJ; Snyder LD; Neely ML; Hellkamp AS; Hotchkin DL; Morrison LD; Bender S; Leonard TB; Culver DA;
Lung; 2022 Feb; 200(1):21-29. PubMed ID: 34997268
[TBL] [Abstract][Full Text] [Related]
7. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
Fan Y; Bender SD; Conoscenti CS; Davidson-Ray L; Cowper PA; Palmer SM; de Andrade JA;
Chest; 2020 Jun; 157(6):1522-1530. PubMed ID: 32004554
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.
Salisbury ML; Conoscenti CS; Culver DA; Yow E; Neely ML; Bender S; Hartmann N; Palmer SM; Leonard TB;
Ann Am Thorac Soc; 2020 Nov; 17(11):1413-1423. PubMed ID: 32574517
[No Abstract] [Full Text] [Related]
9. Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry.
de Andrade JA; Kulkarni T; Neely ML; Hellkamp AS; Case AH; Guntupalli K; Bender S; Conoscenti CS; Snyder LD;
Respir Med; 2021; 189():106637. PubMed ID: 34656903
[TBL] [Abstract][Full Text] [Related]
10. Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
King CS; Ignacio RV; Khangoora V; Nyquist A; Singhal A; Thomas C; Cantres OF; Aryal S; Shlobin OA; Flaherty K; Lasky J; Nathan SD
Am J Respir Crit Care Med; 2024 Jan; ():. PubMed ID: 38236191
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
[TBL] [Abstract][Full Text] [Related]
12. Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
Summer R; Todd JL; Neely ML; Lobo LJ; Namen A; Newby LK; Shafazand S; Suliman S; Hesslinger C; Keller S; Leonard TB; Palmer SM; Ilkayeva O; Muehlbauer MJ; Newgard CB; Roman J
Respir Res; 2024 Jan; 25(1):58. PubMed ID: 38273290
[TBL] [Abstract][Full Text] [Related]
13. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
[TBL] [Abstract][Full Text] [Related]
14. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.
O'Brien EC; Hellkamp AS; Neely ML; Swaminathan A; Bender S; Snyder LD; Culver DA; Conoscenti CS; Todd JL; Palmer SM; Leonard TB;
Chest; 2020 May; 157(5):1188-1198. PubMed ID: 31954102
[TBL] [Abstract][Full Text] [Related]
15. Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry.
Snyder LD; Mosher C; Holtze CH; Lancaster LH; Flaherty KR; Noth I; Neely ML; Hellkamp AS; Bender S; Conoscenti CS; de Andrade JA; Whelan TP
BMJ Open Respir Res; 2020 Jul; 7(1):. PubMed ID: 32624493
[TBL] [Abstract][Full Text] [Related]
16. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
[TBL] [Abstract][Full Text] [Related]
17. Lung function trajectories in patients with idiopathic pulmonary fibrosis.
Neely ML; Hellkamp AS; Bender S; Todd JL; Liesching T; Luckhardt TR; Oldham JM; Raj R; White ES; Palmer SM
Respir Res; 2023 Aug; 24(1):209. PubMed ID: 37612608
[TBL] [Abstract][Full Text] [Related]
18. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
Yoon JH; Nouraie M; Chen X; Zou RH; Sellares J; Veraldi KL; Chiarchiaro J; Lindell K; Wilson DO; Kaminski N; Burns T; Trejo Bittar H; Yousem S; Gibson K; Kass DJ
Respir Res; 2018 Oct; 19(1):195. PubMed ID: 30285867
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study.
Khor YH; Gutman L; Abu Hussein N; Johannson KA; Glaspole IN; Guler SA; Funke-Chambour M; Geiser T; Goh NSL; Ryerson CJ
Chest; 2021 Sep; 160(3):994-1005. PubMed ID: 33905679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
